MRS1220 [CAS 183721-15-5]
Partner: MedChemexpress LLC
| CAS No: | 183721-15-5 |
| Applications: | Cancer-programmed cell death |
| MW: | 403.82 |
| Formula: | C21H14ClN5O2 |
| SMILES: | O=C(NC1=NC2=C(C=C(Cl)C=C2)C3=NC(C4=CC=CO4)=NN13)CC5=CC=CC=C5 |
| Purity: | 99.50 |
| Description: | MRS1220, a highly potent and selective human A3 adenosine receptor (hA3AR) antagonist with a Ki of 0.59 nM, has therapeutic potential for the research of diseases of the central nervous system[1]. MRS1220 reduces glioblastoma tumor size and blood vessel formation in vivo[2]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
